Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

A More Cautious Approach To AI, And Other Policy And Regulation Trends From HIMSS 24

Mar 19 2024

• By Hannah Daniel

• Source: HIMSS

Related Content

FDA Publishes Final Guidance On Clinical Decision Support Software, Clarifies What Software Should Be Regulated As Medical Devices

Sep 29 2022

Chatbots Are Not Ready To Be Medical Devices, Experts Argue

Jul 07 2023

AI Development Should Utilize ‘Health Equity By Design’ Principle

Oct 26 2023

Cox Survey Finds Federal Regulations Are Lowest Barrier To Becoming A ‘Smart Hospital’

May 01 2023

What Should Be Included In PAHPA's Reauthorization?

Apr 04 2023

News We’re Watching: New Cybersecurity Standard; CMS Prodded On TCET; Olympus Scopes Recalled

Mar 01 2024

AI Clinical Summarization Tools Sit In 'Regulatory Grey Area', Experts Warn

Mar 01 2024

European Parliament Adopts AI Act, But Success Hangs On The AI Office

Mar 14 2024

UnitedHealth Group Cyber Attack Disrupts Major Pharmacies For A Week With No End In Sight

Feb 27 2024

Don’t Worry, You (Probably) Won’t Have To Deal With ONC: Algorithm Transparency Rule May Have Surprise Effects On Medtech Firms

Jan 18 2024

Additional Topics

International United States South Korea Asia Pacific Digital Health Policy Cybersecurity Legislation Medical Device

More from Digital Technologies

More from Medtech Insight

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.